In this episode, host Laura Vidal, VP of Oncology at Fortrea, sits down with Dr. Ron Korn, Founder and Chief Medical Officer of Imaging Endpoints, to explore the evolving role of imaging in precision oncology. The conversation covers the latest advancements in molecular imaging, including PSMA PET for prostate cancer and the integration of AI-driven radiomics in clinical trials. The episode highlights how imaging is transforming patient selection, early response identification, and the design of clinical studies.

Listeners will gain an understanding of the challenges and opportunities in aligning imaging with liquid biopsy data, the rise of theranostics, and the regulatory landscape shaping the future of drug development. With practical examples and visionary perspectives, this attachment offers a comprehensive look at how imaging endpoints are driving innovation in oncology and beyond.

If you’re involved in clinical research or interested in the future of medical imaging, this episode—is a must-listen.